Blankinship & Foster’s Pfizer PFE Stock Holding History

Blankinship & Foster’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	10,851 -4	-0%	-$105	0.05%	68
2026 Q1	$305K	Hold	10,855	–	–	0.07%	60
2025 Q4	$270K	Sell	10,855 -10	-0.1%	-$252	0.06%	65
2025 Q3	$277K	Buy	10,865 +98	+0.9%	+$2.42K	0.06%	62
2025 Q2	$261K	Buy	+10,767	New	+$251K	0.06%	65
2022 Q3	–	Sell	-3,979	Closed	-$209K	–	54
2022 Q2	$209K	Sell	3,979 -212	-5%	-$10.8K	0.1%	53
2022 Q1	$217K	Hold	4,191	–	–	0.09%	51
2021 Q4	$247K	Buy	+4,191	New	+$208K	0.09%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blankinship & Foster's PFE Position: Q2 2026 in Review

Blankinship & Foster reduced its Pfizer (PFE) stake by 0.04% in Q2 2026, selling an estimated $105 and leaving 10,851 shares worth $261K. The position accounts for 0.05% of the portfolio, ranked #68.

Blankinship & Foster first reported a position in PFE in Q4 2021 and has held it in 8 quarters since. The position peaked at $305K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Blankinship & Foster held 10,851 shares of Pfizer worth $261K as of Q2 2026.
Blankinship & Foster sold 4 Pfizer shares in Q2 2026, an estimated $105.
Pfizer made up 0.05% of Blankinship & Foster's portfolio in Q2 2026, its #68 holding.
Blankinship & Foster first reported a position in Pfizer in Q4 2021 and has held it in 8 quarters since.
Blankinship & Foster's Pfizer position peaked at $305K in Q1 2026.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blankinship & Foster's 13F filing for Q2 2026, filed 31 Jul 2026.